Cargando…
Effect of arginine vasopressin on systemic and pulmonary arterial pressure in a patient with pulmonary hypertension secondary to pulmonary emphysema: a case report
Although data from several studies support the use of arginine vasopressin (AVP) for the treatment of hypotension concomitant with pulmonary hypertension (PH) in the cardiac surgery setting, to our knowledge, no previous studies have reported the effect of AVP on the systemic and pulmonary circulati...
Autores principales: | Mizota, Toshiyuki, Fujiwara, Kohei, Hamada, Miho, Matsukawa, Shino, Segawa, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813718/ https://www.ncbi.nlm.nih.gov/pubmed/29492440 http://dx.doi.org/10.1186/s40981-016-0072-3 |
Ejemplares similares
-
Low preoperative regional cerebral oxygen saturation in hemodialysis patients
por: Matsukawa, Shino, et al.
Publicado: (2017) -
Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019) -
Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension
por: Sato, Takahiro, et al.
Publicado: (2013) -
Arginine vasopressin modulates electrical activity and calcium homeostasis in pulmonary vein cardiomyocytes
por: Huang, Jen-Hung, et al.
Publicado: (2019) -
PULMONARY EMPHYSEMA
Publicado: (1957)